Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea
Chronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea (PNG) CHB prevalence has been estimated to be over 8% and is a leading cause of death. To address this problem, an alliance between the government of Oro Province, a large private employer, and an Australian non...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
World Health Organization Regional Office for the Western Pacific
2020-12-01
|
Series: | Western Pacific Surveillance and Response |
Subjects: | |
Online Access: | https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/764 |
id |
doaj-19a276e3a4bf4620914f6a0d9e6f6100 |
---|---|
record_format |
Article |
spelling |
doaj-19a276e3a4bf4620914f6a0d9e6f61002021-06-11T05:17:54ZengWorld Health Organization Regional Office for the Western PacificWestern Pacific Surveillance and Response2094-73212094-73132020-12-011146910.5365/wpsar.2020.11.3.001Prevalence of chronic hepatitis B in Oro Province, Papua New GuineaAlice Unah Lee0Luke Mair1Bob Kevin2Lily Gandi3Olive Tarumuri4Caroline Lee5Sue Huntley6David Carl Hilmers7University of Sydney, Concord Repatriation General HospitalSheffield Teaching Hospitals, NHS Foundation TrustPopondetta General HospitalSiroga Clinic. New Britain Palm Oil Company, LTDSiroga Clinic. New Britain Palm Oil Company, LTDHepatitis B Free, Sydney, AustraliaHepatitis B Free, Sydney, AustraliaDepartments of Internal Medicine and Pediatrics and Center for Space Medicine, Baylor College of Medicine, Houston (TX), USAChronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea (PNG) CHB prevalence has been estimated to be over 8% and is a leading cause of death. To address this problem, an alliance between the government of Oro Province, a large private employer, and an Australian non-governmental organization was formed which established a CHB test and treat program. Between 2014 and 2019, rapid hepatitis B surface antigen testing on 4068 individuals in Oro Province was performed. The crude prevalence rate was 12.98% and was significantly higher in males (15.26%) than females (10.94%) (p<.001). The rate among children 10 years and under was 4.72%, 12.81% among women of childbearing age (19 to 35 years), and 18.48% in health care workers. These results indicate the need for improved birth-dose vaccination rates and immunization/treatment of women of childbearing age and health care workers to prevent transmission of CHB. https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/764chronic hepatitis bhepatitis b surface antigenpapua new guineaprevalencevertical transmission |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alice Unah Lee Luke Mair Bob Kevin Lily Gandi Olive Tarumuri Caroline Lee Sue Huntley David Carl Hilmers |
spellingShingle |
Alice Unah Lee Luke Mair Bob Kevin Lily Gandi Olive Tarumuri Caroline Lee Sue Huntley David Carl Hilmers Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea Western Pacific Surveillance and Response chronic hepatitis b hepatitis b surface antigen papua new guinea prevalence vertical transmission |
author_facet |
Alice Unah Lee Luke Mair Bob Kevin Lily Gandi Olive Tarumuri Caroline Lee Sue Huntley David Carl Hilmers |
author_sort |
Alice Unah Lee |
title |
Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea |
title_short |
Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea |
title_full |
Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea |
title_fullStr |
Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea |
title_full_unstemmed |
Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea |
title_sort |
prevalence of chronic hepatitis b in oro province, papua new guinea |
publisher |
World Health Organization Regional Office for the Western Pacific |
series |
Western Pacific Surveillance and Response |
issn |
2094-7321 2094-7313 |
publishDate |
2020-12-01 |
description |
Chronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea (PNG) CHB prevalence has been estimated to be over 8% and is a leading cause of death. To address this problem, an alliance between the government of Oro Province, a large private employer, and an Australian non-governmental organization was formed which established a CHB test and treat program. Between 2014 and 2019, rapid hepatitis B surface antigen testing on 4068 individuals in Oro Province was performed. The crude prevalence rate was 12.98% and was significantly higher in males (15.26%) than females (10.94%) (p<.001). The rate among children 10 years and under was 4.72%, 12.81% among women of childbearing age (19 to 35 years), and 18.48% in health care workers. These results indicate the need for improved birth-dose vaccination rates and immunization/treatment of women of childbearing age and health care workers to prevent transmission of CHB. |
topic |
chronic hepatitis b hepatitis b surface antigen papua new guinea prevalence vertical transmission |
url |
https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/764 |
work_keys_str_mv |
AT aliceunahlee prevalenceofchronichepatitisbinoroprovincepapuanewguinea AT lukemair prevalenceofchronichepatitisbinoroprovincepapuanewguinea AT bobkevin prevalenceofchronichepatitisbinoroprovincepapuanewguinea AT lilygandi prevalenceofchronichepatitisbinoroprovincepapuanewguinea AT olivetarumuri prevalenceofchronichepatitisbinoroprovincepapuanewguinea AT carolinelee prevalenceofchronichepatitisbinoroprovincepapuanewguinea AT suehuntley prevalenceofchronichepatitisbinoroprovincepapuanewguinea AT davidcarlhilmers prevalenceofchronichepatitisbinoroprovincepapuanewguinea |
_version_ |
1721383215949676544 |